Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6501 USD | +0.70% | -2.03% | -12.81% |
07/05 | Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy | CI |
04/04 | North American Morning Briefing : Focus Turns to -2- | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.81% | 1.37Cr | |
+29.03% | 4.92TCr | |
-0.10% | 4.21TCr | |
+48.32% | 4.04TCr | |
-5.26% | 2.89TCr | |
+11.48% | 2.61TCr | |
-22.74% | 1.87TCr | |
+9.06% | 1.33TCr | |
+30.01% | 1.23TCr | |
-1.51% | 1.2TCr |
- Stock Market
- Equities
- TRAW Stock
- News Traws Pharma, Inc.
- Transcript : Onconova Therapeutics, Inc., Q2 2023 Earnings Call, Aug 10, 2023